Position in BIIB
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$608,857
+$83,067 QoQ
Shares Held
2,818
-1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#538
of 1,031 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER TRUST & INVESTMENT Co holds $5,569,315 across 10 Drug Manufacturers - General names. BIIB ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,757 | $1,208,135 | |
| 2 | GSK |
GSK plc
|
22,861 | $1,198,373 | |
| 3 | LLY |
ELI LILLY & Co
|
992 | $1,189,834 | |
| 4 | BIIB |
Biogen Inc.
This page
|
2,818 | $608,857 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,147 | $584,670 | |
| 6 | PFE |
Pfizer Inc
|
18,965 | $456,677 | |
| 7 | ABBV |
AbbVie Inc.
|
1,020 | $256,672 | |
| 8 | MRK |
Merck & Co., Inc.
|
468 | $60,138 |
All Filings in BIIB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $608,857 | 2,818 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $525,790 | 2,868 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $502,803 | 2,857 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $406,232 | 2,900 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $363,583 | 2,895 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $373,162 | 2,727 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||